Global Diabetic Macular Edema Therapeutics Market Size, Status and Forecast 2022

Published On: Sep 2017

Format: PDF

Publisher: QY Research

Pages: 114

Report ID: 118618


This report studies the global Diabetic Macular Edema Therapeutics market, analyzes and researches the Diabetic Macular Edema Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Genentech USA
Eyetech Pharmaceuticals
Bausch & Lomb
Alimera Sciences
Allergan
SurModics
Birken AG
Stratatech Corporation
Fibrocell Science
GlaxoSmithKline Plc
InMed Pharmaceuticals
Karus Therapeutics Limited
RegeneRx Biopharmaceuticals
Scioderm
Shire Plc
Stratatech Corporation
Federal University of Sao Paulo
HaEmek Medical Center
Cornea and Laser Eye Institute
Democritus University of Thrace
Isfahan University of Medical Sciences
Al-Noor Eye Hospital
Azienda Ospedaliera-Universitaria Di Modena
Azienda Ospedaliera Universitaria Senese
Department of Health
Emory University

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Diabetic Macular Edema Therapeutics can be split into
Focal Laser Treatments
Grid Laser Treatments
Anti-VEGF Therapies
Corticosteroid Therapies
Implants

Market segment by Application, Diabetic Macular Edema Therapeutics can be split into
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Other


Table of Contents

Global Diabetic Macular Edema Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of Diabetic Macular Edema Therapeutics
1.1 Diabetic Macular Edema Therapeutics Market Overview
1.1.1 Diabetic Macular Edema Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Diabetic Macular Edema Therapeutics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Diabetic Macular Edema Therapeutics Market by Type
1.3.1 Focal Laser Treatments
1.3.2 Grid Laser Treatments
1.3.3 Anti-VEGF Therapies
1.3.4 Corticosteroid Therapies
1.3.5 Implants
1.4 Diabetic Macular Edema Therapeutics Market by End Users/Application
1.4.1 Hospitals
1.4.2 Ambulatory Surgical Centers
1.4.3 Ophthalmic Clinics
1.4.4 Other

2 Global Diabetic Macular Edema Therapeutics Competition Analysis by Players
2.1 Diabetic Macular Edema Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Genentech USA
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Diabetic Macular Edema Therapeutics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Eyetech Pharmaceuticals
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Diabetic Macular Edema Therapeutics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Bausch & Lomb
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Diabetic Macular Edema Therapeutics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Alimera Sciences
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Diabetic Macular Edema Therapeutics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Allergan
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Diabetic Macular Edema Therapeutics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 SurModics
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Diabetic Macular Edema Therapeutics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Birken AG
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Diabetic Macular Edema Therapeutics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Stratatech Corporation
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Diabetic Macular Edema Therapeutics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Fibrocell Science
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Diabetic Macular Edema Therapeutics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 GlaxoSmithKline Plc
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Diabetic Macular Edema Therapeutics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 InMed Pharmaceuticals
3.12 Karus Therapeutics Limited
3.13 RegeneRx Biopharmaceuticals
3.14 Scioderm
3.15 Shire Plc
3.16 Stratatech Corporation
3.17 Federal University of Sao Paulo
3.18 HaEmek Medical Center
3.19 Cornea and Laser Eye Institute
3.20 Democritus University of Thrace
3.21 Isfahan University of Medical Sciences
3.22 Al-Noor Eye Hospital
3.23 Azienda Ospedaliera-Universitaria Di Modena
3.24 Azienda Ospedaliera Universitaria Senese
3.25 Department of Health
3.26 Emory University

4 Global Diabetic Macular Edema Therapeutics Market Size by Type and Application (2012-2017)
4.1 Global Diabetic Macular Edema Therapeutics Market Size by Type (2012-2017)
4.2 Global Diabetic Macular Edema Therapeutics Market Size by Application (2012-2017)
4.3 Potential Application of Diabetic Macular Edema Therapeutics in Future
4.4 Top Consumer/End Users of Diabetic Macular Edema Therapeutics

5 United States Diabetic Macular Edema Therapeutics Development Status and Outlook
5.1 United States Diabetic Macular Edema Therapeutics Market Size (2012-2017)
5.2 United States Diabetic Macular Edema Therapeutics Market Size and Market Share by Players (2016 and 2017)

6 EU Diabetic Macular Edema Therapeutics Development Status and Outlook
6.1 EU Diabetic Macular Edema Therapeutics Market Size (2012-2017)
6.2 EU Diabetic Macular Edema Therapeutics Market Size and Market Share by Players (2016 and 2017)

7 Japan Diabetic Macular Edema Therapeutics Development Status and Outlook
7.1 Japan Diabetic Macular Edema Therapeutics Market Size (2012-2017)
7.2 Japan Diabetic Macular Edema Therapeutics Market Size and Market Share by Players (2016 and 2017)

8 China Diabetic Macular Edema Therapeutics Development Status and Outlook
8.1 China Diabetic Macular Edema Therapeutics Market Size (2012-2017)
8.2 China Diabetic Macular Edema Therapeutics Market Size and Market Share by Players (2016 and 2017)

9 India Diabetic Macular Edema Therapeutics Development Status and Outlook
9.1 India Diabetic Macular Edema Therapeutics Market Size (2012-2017)
9.2 India Diabetic Macular Edema Therapeutics Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Diabetic Macular Edema Therapeutics Development Status and Outlook
10.1 Southeast Asia Diabetic Macular Edema Therapeutics Market Size (2012-2017)
10.2 Southeast Asia Diabetic Macular Edema Therapeutics Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Diabetic Macular Edema Therapeutics Market Size (Value) by Regions (2017-2022)
11.1.1 United States Diabetic Macular Edema Therapeutics Revenue and Growth Rate (2017-2022)
11.1.2 EU Diabetic Macular Edema Therapeutics Revenue and Growth Rate (2017-2022)
11.1.3 Japan Diabetic Macular Edema Therapeutics Revenue and Growth Rate (2017-2022)
11.1.4 China Diabetic Macular Edema Therapeutics Revenue and Growth Rate (2017-2022)
11.1.5 India Diabetic Macular Edema Therapeutics Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Diabetic Macular Edema Therapeutics Revenue and Growth Rate (2017-2022)
11.2 Global Diabetic Macular Edema Therapeutics Market Size (Value) by Type (2017-2022)
11.3 Global Diabetic Macular Edema Therapeutics Market Size by Application (2017-2022)

12 Diabetic Macular Edema Therapeutics Market Dynamics
12.1 Diabetic Macular Edema Therapeutics Market Opportunities
12.2 Diabetic Macular Edema Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Diabetic Macular Edema Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Diabetic Macular Edema Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source